Article
Modulation of disease risk according to a cathepsin D / apolipoprotein E genotype in Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) - 1 Jul 2003
Schulte T, Böhringer S, Schöls L, Müller T, Fischer C, Riess O, Przuntek H, Berger K, Epplen J T, Krüger R
Abstract excerpt
Aspartyl protease Cathepsin D (CTSD) has been suggested to play a role in the pathogenesis of sporadic Alzheimer's disease (AD) due to interference with protein degradation mechanisms. A C224T (A38V) polymorphism in exon 2 of the CTSD gene is reported to be associated with an increased risk for AD. The partially overlapping pathology between AD and Parkinson's disease (PD) led us to investigate the role of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
